Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Advanced Nasopharyngeal Carcinoma
16%
Antigen-specific
16%
Autoimmunity
16%
CD4+ T
16%
CD8+
16%
Clinical Setting
16%
Cytokine Release
16%
Cytotoxicity
16%
Effective Treatment
16%
Engineered T Cells
16%
Epithelial Tumors
16%
Epstein-Barr Virus
100%
Epstein-Barr Virus-associated Malignancy
16%
Gene Transfer
100%
Human Leukocyte Antigen
100%
In Vitro Culture
16%
Latent Membrane Protein 1 (LMP1)
66%
Lymphoblastoid Cell Lines
16%
Lymphoma
16%
Modified Forms
16%
Mouse Model
16%
Nasopharyngeal Carcinoma
100%
Nasopharyngeal Carcinoma Cells
16%
New Human Leukocyte Antigen Allele
16%
Optimized Expression
16%
Post-transplant Lymphoproliferative Disorder
16%
Self-antigen
16%
T Cell Receptor
33%
T Cell Targeting
16%
T Cells
50%
T-cell Receptor Genes
100%
Tumor Growth
16%
Viral Antigen
16%
Viral Proteins
16%
Virus-specific T Cells
100%
Immunology and Microbiology
Allele
14%
Antigen
14%
Antigen Specificity
14%
Autoimmunity
14%
CD8
14%
Cytokine Release
14%
Cytotoxicity
14%
Epstein Barr Virus
100%
Gene Transfer
100%
Human Leukocyte Antigen
100%
In Vitro
14%
Lymphoblastoid Cell Line
14%
Mouse Model
14%
Nasopharyngeal Carcinoma Cell Line
14%
T Cell
100%
T Cell Receptor
100%
T-Helper Cell
14%
Viral Protein
14%
Virus
14%
Virus Antigen
14%
Wild Type
14%